Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Beta Drugs IPO and CMM Infraprojects IPO.
Beta Drugs IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while CMM Infraprojects IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | Systematix Corporate Services Limited |
| Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹19.52 Cr whereas the issue size of the CMM Infraprojects IPO is up to ₹18.18 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of CMM Infraprojects IPO is ₹40.00 per share.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹40.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 22,96,000 shares | 45,45,000 shares |
| Issue Size Total (Amount) | up to ₹19.52 Cr | up to ₹18.18 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while CMM Infraprojects IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and CMM Infraprojects IPO is Oct 04, 2017, and Oct 04, 2017, respectively.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 04, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to CMM Infraprojects IPO P/E ratio of .
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO retail investors (RII) are offered while in CMM Infraprojects IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Beta Drugs IPO and in CMM Infraprojects IPO.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Beta Drugs IPO subscribed in total, whereas CMM Infraprojects IPO subscribed .
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
